Cigna’s Evernorth Commits $100M to AI Pharmacy Forward, Targeting $400M Value by 2028
CI•Evernorth, Cigna’s health services division, is investing $100 million through 2028 to launch Pharmacy Forward, an AI-powered specialty program with Accredo Specialty Pharmacy. It aims to halve prescription processing times, lift medication adherence above 80%, secure same-day shipping for 90% of patients and deliver $400 million value by 2028.
1. Launch and Investment
Evernorth, the health services arm of Cigna, unveiled Pharmacy Forward with a $100 million commitment through 2028, partnering initially with Accredo Specialty Pharmacy’s Therapeutic Resource Centers to streamline specialty medication support for patients managing complex conditions.
2. AI-Driven Enhancements
The program deploys AI across core functions: it integrates predictive analytics to boost medication adherence above 80% and cut clinician documentation time by up to 50%, halves prescription processing timelines, adds AI-enabled scheduling and digital pathways that could increase self-service uptake by 25%, and optimizes fulfillment to ensure 90% of patients are within a one-day ground shipping radius.
3. Financial Impact and Expansion
Pharmacy Forward is set to generate $400 million in value by the end of 2028 while serving over one million patients annually, with plans to extend AI-enabled capabilities to other Evernorth pharmacy operations to further enhance care coordination and operational efficiency.
